EGFR and head and neck squamous cell carcinoma: Even though EGFR expression does not seem to be a predictive marker in HNSCC,15 the presence of an EGFR variant, EGFRvIII, which is a truncated form of EGFR, is present in approximately 40% of cetuximab‐resistant HNSCC.16, 17